These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27550090)

  • 1. Functions of interleukin-34 and its emerging association with rheumatoid arthritis.
    Zhou RP; Wu XS; Xie YY; Dai BB; Hu W; Ge JF; Chen FH
    Immunology; 2016 Dec; 149(4):362-373. PubMed ID: 27550090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
    Xu WD; Zhang M; Zhang YJ; Ye DQ
    Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
    Xie Q; Huang C; Li J
    Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-32 with potential insights into rheumatoid arthritis.
    Xu WD; Zhang M; Feng CC; Yang XK; Pan HF; Ye DQ
    Clin Immunol; 2013 May; 147(2):89-94. PubMed ID: 23578550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.
    Garcia S; Hartkamp LM; Malvar-Fernandez B; van Es IE; Lin H; Wong J; Long L; Zanghi JA; Rankin AL; Masteller EL; Wong BR; Radstake TR; Tak PP; Reedquist KA
    Arthritis Res Ther; 2016 Mar; 18():75. PubMed ID: 27036883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.
    Tian Y; Shen H; Xia L; Lu J
    J Interferon Cytokine Res; 2013 Jul; 33(7):398-401. PubMed ID: 23421370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
    Narazaki M; Tanaka T; Kishimoto T
    Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-34 as a promising clinical biomarker and therapeutic target for inflammatory arthritis.
    Udomsinprasert W; Jittikoon J; Honsawek S
    Cytokine Growth Factor Rev; 2019 Jun; 47():43-53. PubMed ID: 31126875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.
    Moon SJ; Hong YS; Ju JH; Kwok SK; Park SH; Min JK
    J Rheumatol; 2013 Nov; 40(11):1842-9. PubMed ID: 23996288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targets for rheumatoid arthritis: Progress and promises.
    Alghasham A; Rasheed Z
    Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting interleukin-21 in rheumatoid arthritis.
    Yuan FL; Hu W; Lu WG; Li X; Li JP; Xu RS; Li CW; Chen FH; Jin C
    Mol Biol Rep; 2011 Mar; 38(3):1717-21. PubMed ID: 20848219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of anti-interleukin-20 monoclonal antibody.
    Hsu YH; Chang MS
    Cell Transplant; 2014; 23(4-5):631-9. PubMed ID: 24816455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th22 Cells Promote Osteoclast Differentiation
    Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
    Front Immunol; 2018; 9():2901. PubMed ID: 30619268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-32, a proinflammatory cytokine in rheumatoid arthritis.
    Joosten LA; Netea MG; Kim SH; Yoon DY; Oppers-Walgreen B; Radstake TR; Barrera P; van de Loo FA; Dinarello CA; van den Berg WB
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3298-303. PubMed ID: 16492735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological roles for IL-18 in inflammatory arthritis.
    Matsui K; Tsutsui H; Nakanishi K
    Expert Opin Ther Targets; 2003 Dec; 7(6):701-24. PubMed ID: 14640907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.